Guidelines for the Prevention and Control
of Meningococcal Disease
References
- Health Canada. Guidelines for control of meningococcal
disease. CCDR 1994;20(3):17-27.
- Squires SG, Deeks SL, Tsang RSW. Enhanced surveillance of
invasive meningococcal disease in Canada, 1 January, 1999, through
31 December, 2001. CCDR 2004;30(3):17-28.
- Whalen CM, Hockin JC, Ryan A, et al. The changing
epidemiology of invasive meningococcal disease in Canada, 1985
through 1992. Emergence of a virulent clone of Neisseria
meningitidis. JAMA 1995;273:390-94.
- Deeks S, Kertesz D, Ryan A et al. Surveillance of invasive
meningococcal disease in Canada, 1995-1996. CCDR
1997;23(16):121-25.
- Squires SG, Pelletier L, Mungai M et al. Invasive
meningococcal disease in Canada, 1 January, 1997, to 31 December,
1998. CCDR 2000;26(21):177-82.
- Varughese PV, Carter AO. Meningococcal disease in Canada.
Surveillance summary to 1987. CCDR 1989;15(17):89-96.
- Ashton FE, Ryan JA, Borczyk A et al. Emergence of a
virulent clone of Neisseria meningitidis serotype
2a that is associated with meningococcal serogroup C disease in
Canada. J Clin Microbiol 1991;29:2489-93.
- Ragunathan L, Ramsay M, Borrow R et al. Clinical features,
laboratory findings and management of meningococcal meningitis in
England and Wales: report of a 1997 survey. Meningococcal
meningitis: 1997 survey report. J Infect 2000;40:74-9.
- De Wals P, Hertoghe L, Borlée-Grimée I et al. Meningococcal disease in Belgium. Secondary attack rate among
household, day-care nursery and pre-elementary school
contacts. J Infect 1981;3(suppl 1):53-61.
- Meningococcal Disease Surveillance Group. Meningococcal
disease: secondary attack rate and chemoprophylaxis in the United
States, 1974. JAMA 1976;235:261-65.
- Cooke RPD, Riordan T, Jones DM et al. Secondary cases of
meningococcal infection among close family and household contacts
in England and Wales, 1985–1987. Br Med J
1989;298:555-58.
- Hastings L, Stuart J, Andrews N et al. A retrospective
survey of clusters of meningococcal disease in England and Wales,
1993 to 1995: estimated risks of further cases in household and
educational setting. Commun Dis Rep 1997;7(13):R195-R200.
- Kaiser AB, Hennekens CH, Saslaw MS et al. Seroepidemiology
and chemoprophylaxis of disease due to sulfonamide- resistant Neisseria meningitidis in a civilian
population. J Infect Dis 1974;130:217-24.
- Jacobson JA, Camargos PAM, Ferreira JT et al. The risk of
meningitis among classroom contacts during an epidemic of
meningococcal disease. Am J Epidemiol 1976;104:552-55.
- Feigin RD, Baker CJ, Herwaldt L et al. Epidemic
meningococcal disease in an elementary-school classroom. N
Engl J Med 1982;307:1255-57.
- Hudson PJ, Vogt RL, Heun EM et al. Evidence for school
transmission of Neisseria meningitidis during a
Vermont outbreak. Pediatr Infect Dis J 1986;5:213-17.
- Pollard AJ, Begg N. Meningococcal disease and healthcare
workers [Editorial]. Br Med J 1999;319:1147-48.
- Gehanno J-F, Kohen-Couderc L, Lemeland J-F et al. Nosocomial meningococcaemia in a physician. Infect Control
Hosp Epidemiol 1999;20:564-65.
- Centers for Disease Control and Prevention. Immunization of
health-care workers: recommendations of the Advisory Committee on
Immunization Practices (ACIP) and the Hospital Infection Control
Practices Advisory Committee (HICPAC). MMWR
1997;46(RR18):1-42.
- Stroffolini T, Rosmini F, Curiano CM. A one year survey of
meningococcal disease in Italy. Eur J Epidemiol
1987;3:399-403.
- Olivares R, Hubert B. Clusters of meningococcal disease in
France (1987-1988). Eur J Epidemiol 1992;8:737-42.
- Almog R, Block C, Gdalevich M et al. First recorded
outbreaks of meningococcal disease in the Israel Defence Force:
three clusters due to serogroup C and the emergence of resistance
to rifampicin. Infection 1994;22:69-71.
- Samuelsson S, Hansen ET, Osler M et al. Prevention of
secondary cases of meningococcal disease in Denmark. Epidemiol
Infect 2000;124:433-40.
- Dawson SJ, Fey RE, McNulty CA. Meningococcal disease in
siblings caused by rifampicin sensitive and rifampicin resistant
strains. Commun Dis Public Health 1999;2:215-16.
- Guiver M, Borrow R, Marsh J et al. Evaluation of the
Applied Biosystems automated Taqman polymerase chain reaction
system for the detection of meningococcal DNA. FEMS Immunol
Med Microbiol 2000;28:173-79.
- Newcombe J, Cartwright K, Palmer WH et al. PCR of
peripheral blood for diagnosis of meningococcal disease. J
Clin Microbiol 1996;34:1637-40.
- Carrol ED, Thomson AP, Shears P et al. Performance
characteristics of the polymerase chain reaction assay to confirm
clinical meningococcal disease. Arch Dis Child
2000;83:271-73.
- British Columbia Ministry of Health. Communicable disease
control: invasive meningococcal disease. January 2001.
- Purcell B, Samuelsson S, Hahne SJM et al. Effectiveness of
antibiotics in preventing meningococcal disease after a case:
systematic review. Br Med J 2004;328:1339-42.
- Communicable Diseases Network Australia. Guidelines for the
early clinical and public health management of meningococcal
disease in Australia. Commonwealth of Australia, 2001. ISBN 0
642 50308 7.
- Stuart JM, Gilmore AB, Ross A et al. Preventing secondary
meningococcal disease in health care workers: recommendations of a
working group of the PHLS Meningococcus Forum. Communic Dis
Pub Health 2001;4(2):102-05.
- Public Health Laboratory Service Meningococcus Forum. Guidelines for public health management of meningococcal
disease in the UK. Commun Dis Public Health.
2002;5(3):187-204.
- National Advisory Committee on Immunization. Statement on
recommended use of meningococcal vaccines. CCDR
2001;27(ACS-6):2-36.
- Healing TD, Hoffman PN, Young SEJ. The infection hazards of
human cadavers. Communic Dis Rep CDC Rev 1995;5:R61-R68.
- Health Canada. Infection Control Guidelines – Routine practices and additional precautions for preventing the
transmission of infection in health care. CCDR
1999;25(S4):1-142.
- Centers for Disease Control and Prevention. Exposure to
patients with meningococcal disease on aircrafts – United
States 1999-2001. MMWR 2001;50(23):485-89.
- Kenyon TA, Valway SE, Ihle WW et al. Transmission of
multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med
1996;334:933-38.
- Kristiansen B-E, Knapsbog A-B. Secondary prevention of
meningococcal disease. Br Med J 1996;312:591-92.
- DeWals P. Notice concerning the use of a vaccine to control
an outbreak of invasive meningococcal infections. On behalf of
the Advisory Committee to the ministère de la santé
et des Services Sociaux du Québec, 2001.
- Centers for Disease Control and Prevention. Meningococcal
disease and college students. MMWR 2000;49(RR07):11-20.
- Schwartz B. Chemoprophylaxis for bacterial infections:
principles of an application to meningococcal infections. Rev
Infect Dis 1991;13(suppl 2):S170-S173.
- Judson FN, Ehret JM. Single-dose ceftriaxone to eradicate
pharyngeal Neisseria meningitidis. Lancet
1984;2:462-1463.
- Schwartz B, Al-Tobaiqi A, Al-Ruwais A et al. Comparative
efficacy of ceftriaxone and rifampin in eradicating pharyngeal
carriage of group A Neisseria meningitidis. Lancet 1988;1:1239-42.
- Girgis N, Sultan Y, Frenck RW et al. Azithromycin compared
with rifampin for eradication of nasopharyngeal colonization of Neisseria meningitidis. Pediatr Infect Dis J
1998;17(9):816-19.
- Gonzalez de Aledo LA, Garcia MJ. Control of a school
outbreak of serogroup B meningococcal disease by chemoprophylaxis
with azithromycin and ciprofloxacin. An Esp Pediatr
2000;53(5):412-17.
- National Advisory Committee on Immunization. Supplementary
statement on conjugate meningococcal vaccines. CCDR
2003;29(ACS-6):10-11.
- Health Canada. Meningococcal vaccine. In: Canadian
immunization guide, 6th edition. Ottawa: Health
Canada, 2002;151-65. Cat. H49-8/2002E.
- Granoff DM, Gupta RK, Belshe RB et al. Induction of
immunologic refractoriness in adults by meningococcal C
polysaccharide vaccination. J Infect Dis 1988;178:870-74.
- Richmond P, Kaczmarski E, Borrow R et al. Meningococcal C
polysaccharide vaccine induces immunologic hyporesponsiveness in
adults that is overcome by meningococcal C conjugate vaccine. J Infect Dis 2000;181:761-64.
- MacLennan J, Obaro S, Deeks J et al. Immunologic memory 5
years after meningococcal A/C conjugate vaccination in
infancy. J Infect Dis 2001;183:97-104.
[Previous] [Table of
Contents]